Calidi Biotherapeutics, Inc. SEC filings CLDI
Calidi Biotherapeutics, Inc. has 406 filings in SEC EDGAR's recent list, going back to May 17, 2021. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (listing notice, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice, Other events
|
Sep 25, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 22, 2026 | Sep 17, 2026 |
| 424B5 | Prospectus supplement | Sep 17, 2026 | — |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 31, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jul 16, 2026 | Jul 10, 2026 |
| 3 | Initial insider ownership | Jun 29, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jun 23, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 12, 2026 |
| DEFA14A | Additional proxy material | Jun 5, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 29, 2026 | May 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 8, 2026 | May 6, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 2, 2026 | Mar 29, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Mar 31, 2026 | — |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 11, 2026 | Mar 5, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Mar 9, 2026 | — |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| S-3MEF | Filing | Mar 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 4, 2026 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 29, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets
|
Oct 31, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Sep 19, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 29, 2025 | Aug 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 27, 2025 | — |
| 3 | Initial insider ownership | Aug 27, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 25, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 22, 2025 | Aug 20, 2025 |
| 424B4 | Prospectus | Aug 21, 2025 | — |
| EFFECT | Filing | Aug 20, 2025 | — |
| CORRESP | Letter to the SEC | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 19, 2025 | — |
| S-1 | Registration statement | Aug 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 14, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 7, 2025 | Aug 4, 2025 |
| EFFECT | Filing | Jul 25, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jul 25, 2025 | Jul 24, 2025 |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2025 | — |
| S-3 | Shelf registration | Jul 18, 2025 | — |
| 4 | Insider transaction | Jul 15, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 9, 2025 |
| EFFECT | Filing | Jul 11, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 11, 2025 | Jul 9, 2025 |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 10, 2025 | Jul 9, 2025 |
| UPLOAD | Letter from the SEC | Jul 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2025 | — |
| S-1 | Registration statement | Jul 3, 2025 | — |
| DRS | Filing | Jul 2, 2025 | — |
| DEFA14A | Additional proxy material | May 23, 2025 | — |
| DEF 14A | Proxy statement | May 23, 2025 | May 23, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Auditor change
|
May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 25, 2025 | Apr 22, 2025 |
| 3 | Initial insider ownership | Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
|
Apr 23, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 1, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K/A | Amended current report | Feb 10, 2025 | Feb 10, 2025 |
| EFFECT | Filing | Feb 7, 2025 | — |
| CORRESP | Letter to the SEC | Feb 6, 2025 | — |
| 424B5 | Prospectus supplement | Feb 5, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Agreement ended, Results of operations, Regulation FD disclosure
|
Jan 28, 2025 | Jan 23, 2025 |
| UPLOAD | Letter from the SEC | Jan 15, 2025 | — |
| S-3 | Shelf registration | Jan 10, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 8, 2025 |
| 424B5 | Prospectus supplement | Jan 10, 2025 | — |
| 424B5 | Prospectus supplement | Jan 8, 2025 | — |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Dec 27, 2024 | — |
| CORRESP | Letter to the SEC | Dec 26, 2024 | — |
| 4 | Insider transaction | Dec 18, 2024 | Dec 17, 2024 |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| S-1 | Registration statement | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Nov 29, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 15, 2024 | Nov 14, 2024 |
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 424B5 | Prospectus supplement | Nov 14, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 25-NSE | Delisting notice | Oct 28, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 24, 2024 | Oct 23, 2024 |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 424B5 | Prospectus supplement | Oct 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 18, 2024 | Oct 17, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Sep 20, 2024 |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 11, 2024 | Oct 11, 2024 |
| EFFECT | Filing | Oct 10, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| S-3/A | Filing | Oct 7, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| S-3 | Shelf registration | Oct 1, 2024 | — |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2024 | Sep 11, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 11, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 22, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 20, 2024 | Aug 16, 2024 |
| DEF 14A | Proxy statement | Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 29, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 15, 2024 | Jul 10, 2024 |
| 4 | Insider transaction | Jul 11, 2024 | Jul 1, 2024 |
| 3 | Initial insider ownership | Jul 11, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 8, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 5, 2024 | Jul 5, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Mar 29, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Mar 29, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 6, 2024 |
| D | Filing | Jun 6, 2024 | — |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 424B3 | Prospectus | Jun 4, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 4, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 31, 2024 | May 31, 2024 |
| 8-K |
Current report
Officer or director change
|
May 17, 2024 | May 13, 2024 |
| 424B3 | Prospectus | May 16, 2024 | — |
| 8-K |
Current report
Officer or director change
|
May 16, 2024 | May 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | May 9, 2024 | May 9, 2024 |
| SCHEDULE 13D | Ownership over 5% (active) | May 1, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| 4 | Insider transaction | Apr 22, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 19, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Apr 19, 2024 | Apr 14, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2024 | Apr 14, 2024 |
| 424B4 | Prospectus | Apr 17, 2024 | — |
| EFFECT | Filing | Apr 15, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| S-1/A | Amended registration statement | Apr 15, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CLDI (NYSE), CLDWW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855485
- Former names
- Calidi Biotherapeutics, Inc. (until Sep 25, 2026); First Light Acquisition Group, Inc. (until Sep 19, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.